HPi1 Monoclonal Antibody Supernatant from Hybridoma HIC0-4F9 (endocrine cell marker)

Case ID:
1038A
Web Published:
1/29/2015
Description:

Technology Overview: The monoclonal antibody HPi1 is derived from the hybridoma HIC0-4F9. HPi1 selectively reacts with a cell surface molecule on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.

 

Antibody: HPi1 Supernatant

Hybridoma cell line: HICO-4F9

Isotype: Mouse IgG1

Species reactivity: Human

Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry

 

Competitive Environment:  No other antibodies with such specificity are known to exist.

 

Patent Status: Patent application filed.

 

Availability:  1mL supernatant aliquot

 

Patent Information:
For Information, Contact:
Trina Voss
Technology Development Manager
Oregon Health & Science University
503-494-8200
vosst@ohsu.edu
Inventors:
Philip Streeter
Markus Grompe
Craig Dorrell
Stephanie Abraham
Kelsea Shoop
Keywords:
Biological Materials
Biological Materials - Antibodies
Research Tools
Research Tools - Reagents
© 2018. All Rights Reserved. Powered by Inteum